Cervical cytology (conventional, Pap smear)
Screening for precancerous cervical lesions.
The high-risk HPV test detects 14 oncogenic human papillomavirus types, individually identifying types 16 and 18.
Persistent infection with oncogenic HPV types is the primary cause of cervical cancer. The PCR test detects viral DNA in the swab. Combined with cytology (co-testing), it is the most reliable screening method.
Between days 10 and 20 of the cycle, not during menstruation. Refrain from sexual intercourse, vaginal medications, and transvaginal ultrasound for 48 hours prior to the test.
A cervical swab is collected by a physician during a gynecological examination.
No. Most infections resolve on their own, but follow-up with a gynecologist is required.
Screening for precancerous cervical lesions.
Assessment of vaginal microflora, detection of bacterial vaginosis.
Advanced Pap smear with higher accuracy; an HPV test can be added using the same sample.
Identifies specific high- and low-risk HPV types.
Assesses risk in case of a positive HPV test or inconclusive cytology.
Co-testing: cytology and HPV from a single sample — the most comprehensive cervical screening.
Get tested without a referral in Warsaw, 7 days a week.
Book a sample collection Discuss results with a gynecologist
This information is for reference only. Results are interpreted by a doctor.